Cite
HARVARD Citation
Zhang, P. et al. (2022). In vivo acquisition of blaKPC-2 with low biological cost in blaAFM-1-harboring ST463 hypervirulent Pseudomonas aeruginosa from a patient with hematologic malignancy. Journal of global antimicrobial resistance. pp. 189-195. [Online].